- EnglishEN
- Bahasa MalaysiaMS
- Bahasa IndonesiaID
- 中文ZH
- ไทยTH
The chronic diseases shaping Southeast Asia rarely arrive without warning. Neo Nexon reads that warning early, turning a simple DNA sample into clear, personalized insight into the risks behind the region's most common non-communicable diseases.
// heart · metabolic · lifestyle · nutrition · response
Southeast Asia's leading DNA-screening OEM — 120+ partner brands across Malaysia, Indonesia, Thailand and the wider region
Across the region, most DNA screening kits run on one platform. More than 120 clinic, pharmacy, wellness and consumer brands put their name on reports we produce. Neo Nexon is the OEM engine they build on: sequencing, interpretation, reporting and languages, all from one partner.
You put your brand on it. We handle sequencing, analysis, reporting and fulfilment.
One interpretation pipeline stands behind 120+ brands and every report they deliver.
Reports in four languages, with support for teams right across Southeast Asia.
Non-communicable diseases cause more than two thirds of deaths across Southeast Asia, and most are shaped by risk that builds quietly for years. Neo Nexon moves the point of action upstream, from treatment after symptoms to insight before them, so people and the professionals who guide them can act while it still matters most.
A saliva sample is analyzed against genomic markers linked to cardiovascular, metabolic and lifestyle conditions, weighted for Asian populations.
Findings become plain-language, personalized guidance across nutrition, lifestyle and follow-up, ready for a clinician or wellness partner to act on.
As the science grows, reports are refreshed. A single sample keeps delivering value long after the first result.
Add preventive genetic screening to your services, with kits, reporting and support handled end to end.
Give your workforce earlier insight into health risk, and give HR a measurable, proactive wellbeing programme.
Extend preventive and personalized-health programmes with genomic screening and structured, professional reporting.
A Malaysian-owned partner for population-level preventive-health and NCD-screening initiatives, built for scale and local data relevance.
Scientists, counsellors and technologists working side by side, so every partner and every person gets answers they can trust.
A working genomics business, delivering across the region while we build toward something larger.
Wellness, lifestyle and health-risk screening delivered through our ATGC Genomic and Supagene brands.
Kits, genotyping coordination and reporting for clinical and wellness partners across Southeast Asia.
Clear, individualized reports that translate complex genomic data into everyday health decisions.
Working with research and clinical partners to advance genomic understanding of regional populations.
You order kits, we run the genotyping and analysis, and your patients or members receive clear, personalized reports. No agents, no subscriptions, no licence fees, you pay only for the kits you activate.
Every kit returns a clean, visual report your team can talk through in minutes, in print or on screen.
No subscriptions and no licence fees. Transparent, lab-direct pricing, and you only pay for the kits you order.
Fully analyzed reports delivered within 14 to 18 working days of the lab receiving the sample.
Reports carry your clinic or pharmacy logo, design and contact details, so the experience feels like your own.
Color-coded summary pages make consultations fast, in print or on screen, for busy clinics and pharmacies.
Reports in English, Mandarin, Thai and Bahasa Indonesia, with support for teams across the region.
Quality control at every stage and assured data security, trusted by professional partners.
Already a partner? Manage kits and orders through the ATGC platform.
Every sample deepens a genomic picture that is distinctly Southeast Asian. That growing foundation, paired with disciplined data governance, is how Neo Nexon moves from individual reports toward population-scale preventive health.
Genomic insight grounded in regional populations, not borrowed from elsewhere.
Data handled with consent at the centre and protection built into the model.
Sharper, more relevant risk insight as the foundation grows over time.
reports helping people across the region live better within five years.
Preventive genomics only matters if it reaches people. This is the scale we are working toward, one clear insight at a time.
Five-year projection, grounded in a foundation of roughly 14,000 individuals at an average of six insights each.
Geneticists, bioinformaticians, nutrition and clinical advisors, and lab technologists, working across Southeast Asia. The same hands that run the science stand behind every report we deliver.
Analysis carried out through established laboratory partners, with quality control at every stage.
Personal and genomic data managed in line with local data-protection law.
Your data, your choice, at every step of the process.
Reports are designed to support clinicians and wellness partners, not to replace medical advice.
Our microarray, whole-exome and whole-genome tests are run with our laboratory partner. These are the laboratory's certifications, and what each one covers.
BSI certifies the laboratory's quality system for its microarray (DNA chip) and sequencing services.
Valid to Oct 2028
Accredits two of the laboratory's sites for clinical sequencing (NGS) tests.
Accredited to Mar 2028
US federal certificate that lets two of the laboratory's sites test human samples.
Valid to Jan 2027 and Jul 2028
Illumina certifies the laboratory to run its Infinium microarrays and HiSeq sequencers.
No end date
A national government certificate for protecting personal data and information, covering the laboratory's sequencing and diagnostics services.
Valid to Mar 2027
Certificates checked 17 Sep 2026.
Tell us who you serve. We will show you how a partnership works, from kits and reporting to launch.
Prefer email? info@neonexon.com
Download our corporate profile